Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial.
| Image |  |
|---|---|
| Description | scientific article published on 26 July 2013 |
| Author/s |
author: Bruce Neal Diederick Grobbee Ruth Cannata Arlette Weichert Stephen Nicholls A Michael Lincoff John Buse Jean-Claude Tardif |
| Publication date | July 26, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |